Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: Lilly’s radiopharmaceutical buy; strong third quarter for biotech financing; Novartis’s nephropathy results; US ICER runs cost analysis on first batch of drugs; and the outlook for US FTC oversight of biopharma M&A.